AVXL- Alzheimers Phase 1 Clinical Complete for Alzheimers

TheStockProphet Newsletter

AVXL: Alzheimers Phase 1 Clinical Complete for Alzheimers Anavex Life Sciences Corp Symbol: AVXL Price: 1.69 Shares Outstanding: 12/19/2011: 27,187,174 About AVXL:

Anavex Life Sciences Corp. is a specialty pharmaceutical company engaged in the discovery and development of novel drug candidates for the treatment of neurological diseases and cancer. The Anavex proprietary SIGMACEPTOR(TM) Discovery Platform involves the rational design of drug compounds targeted to specific receptors involved in the modulation of multiple cellular biochemical signaling pathways.

Recent News Headline: Anavex successfully completes a Phase 1 clinical trial for ANAVEX 2-73 (Treating Alzheimers) The Chart:

Bullish Triangle/Pennant Formation Breakout Today, Already pounding a longer term trendline.

No selling behavior in here, last sellers bars were 1/17, 1/18 and 1/27 (lower high and lower low) Tomorrow is a trend time line, a day around which a major move can occur Watch 1.74, 1.97 and 2.20 in Rotation up Market is Trending and Longs are Working GLTA Information herein may be forward looking within the meaning of Section twenty seven A of the Securities Act of nineteen hundred thirty three and Section twenty one B of the SEC Act of nineteen hundred thirty four. Statements involving discussions of future events. Don`t rely on them to make a decision. Past performance is never indicative of future results. AVXL is a reporting company pursuant to the voluntary reporting requirements of Section 12g of The Exchange Act of nineteen hundred thirty-four and files annual and quarterly reports under sections 13a-1 and 13a-13 promulgated there under. URGENT: Please, please read those SEC filings before you invest. Make an informed decision. AVXL has an accumulated deficit, no revs in its most recent quarter and a going concern opinion from its auditor. The number of shares outstanding has been increasing. It is not a revenue producing company at this time. We received five thousand dollars from a non-affiliate of the issuer for our services. We may receive more compensation in the future, that nature, amount and source of which cannot be determined at this time. The party that paid us does not have a position in the stock. This is a high risk investment vehicle. WARNING: You can lose all your money buying AVXL. This report shall not be taken as investment advice or solicitation.

Read our full disclaimer now at: http://www.thestockprophet.com/disclaimer.html ~~~~~~~~~~~~~~~~~~~~~~~~~~

TheStockProphet TheStockProphet.com ~~~~~~~~~~~~~~~~~~~~~~~~~~

Forward this email

No related posts.